China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Feasibility clinical study on the safety and effectiveness of NaviLoc Vavle in the treatment of aortic valve insufficiency'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132881
Registration Time: 2026/09/19
Type: Interventional study
Primary Sponsor: Fuwai Central China Cardiovascular Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344073
Published by HT Digital Content Services with permission from Health Daily Digest....